GILEAD 4331 300 (Viread 300 mg)
Generic Name: tenofovir
Pill imprint GILEAD 4331 300 has been identified as Viread 300 mg.
Viread is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 300 mg is not subject to the Controlled Substances Act.
See also related documents.
- Generic Name:
- 300 mg
- 17.00 mm
- Elliptical / Oval
- Prescription only
FD&C Blue No. 2
hypromellose 2910 (15000 mPa.s)
|NDC Code||Manufacturer / Repackager|
|54569-5334||A-S Medication Solutions, LLC (repackager)|
|54868-4669||Physicians Total Care Inc (repackager)|
|68258-9003||Dispensing Solutions Inc. (repackager)|
|35356-0073||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Viread (tenofovir)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.